Karl Tronstad

Karl Johan Tronstad, PhD, is a professor in the Department of Biomedicine, University of Bergen, Bergen, Norway, where he heads the Tronstad Lab which studies cell metabolism and mitochondrial involvement in cancer and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). In 2017, his research group received a grant of 9.5 million for the development of new ME/CFS treatment methods and biomarkers. Dr. Tronstad collaborates with Professor Olav Mella and Øystein Fluge at the Department of Oncology and Medical Physics at Haukeland University Hospital on ME/CFS research.

Notable studies
(Full Text)
 * 2016, Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome
 * 2020, Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - (Full text)
 * 2021, A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome - (Full text)

= Talks and interviews =
 * 2019, Speaker at the 14th Invest in ME International ME Conference; Speech title: Metabolic profiling and associations to clinical data in ME - (Video)

Online presence

 * ResearchGate

Learn more

 * Finding the cause of Chronic Fatigue Syndrome/ME (2017)
 * Tronstad Lab bio page